s
Skip to content Skip to navigation menu

Mycoplasma Detection Kits

Rapid real-time PCR test kits for the detection of mycoplasma contaminations in cell culture media, mammalian cell cultures and cell culture supernatants, or cell-culture derived biologicals for lot release. The first member of the productline qPCR kit for mycoplasma detection, the Microsart AMP Mycoplasma, is a fully validated kit according to EP 2.6.7 for up to 18 ml sample volume. The kit contains all essential components in a function tested ready-to-use master mix including the polymerase.

Microsart® AMP Mycoplasma
Microsart® AMP Mycoplasma
Item no.: SMB95-1002

Reduce your testing time from weeks to 3 hours with the Microsart® AMP Mycoplasma. With the ability to be very flexible in sample volume (up to 18 ml) and sample preparation, the kit is specifically designed for: the control of raw materials, for in-process control, and for lot release testing of finished products.

Show more

Microsart® AMP Mycoplasma
Microsart® AMP Mycoplasma
Item no.: SMB95-1001

Reduce your testing time from weeks to 3 hours with the Microsart® AMP Mycoplasma. With the ability to be very flexible in sample volume (up to 18 ml) and sample preparation, the kit is specifically designed for: the control of raw materials, for in-process control, and for lot release testing of finished products.

Show more

Microsart® ATMP Mycoplasma
Microsart® ATMP Mycoplasma
Item no.: SMB95-1004

The Microsart® ATMP Mycoplasma detection kit is especially designed for an easy and fast detection of mycoplasma in cell-based therapeutics like autologous chondrocyte transplants (ATMPs –advanced therapy medical products). Due to the short shelf life of these therapeutics, a fast result is needed. The PCR-technology makes it possible to reduce the time-to-result to only 3 hours.

Show more

Microsart® ATMP Mycoplasma
Microsart® ATMP Mycoplasma
Item no.: SMB95-1003

The Microsart® ATMP Mycoplasma detection kit is especially designed for an easy and fast detection of mycoplasma in cell-based therapeutics like autologous chondrocyte transplants (ATMPs –advanced therapy medical products). Due to the short shelf life of these therapeutics, a fast result is needed. The PCR-technology makes it possible to reduce the time-to-result to only 3 hours.

Show more